About Us

Pioneering Innovation in Pharmaceutical IP Licensing

BIOSIRIUS Ltd stands at the forefront of biotechnology innovation, transforming valuable intellectual property into breakthrough therapeutic solutions. Founded in 2021 and headquartered in Dorset, UK, we are a specialized pharmaceutical IP licensing company dedicated to bridging the critical gap between groundbreaking scientific discovery and patient access to life-changing treatments

Meet The Team

Dr Syed Nasser

Founder and Director

Dr Syed Nasser is an Intensive Care Doctor and researcher in IL–18 biology. Dr Nasser is the CEO of BIOSIRIUS Ltd and the Inventor. He is in the process of undertaking a PhD looking at the IL–18 axis in sepsis, a major cause of morbidity and mortality in the world

Dr Shuaib Nasser

Founder and Clinical Director

Dr Shuaib Nasser is a Consultant in allergy and asthma at Cambridge University Hospitals NHS Foundation Trust and serves on the NICE board for drug approval, as well as sat as advisor on boards for advisory boards for GSK, TEVA and Novartis. Author of over 100 publications and winner of the William Frankland BSACI award for outstanding services to allergy.

Dr Rainer Doffinger

Founder and Scientific Expert

Dr Rainer Doffinger is a Consultant Clinical Scientist in Immunology and head of the Cytokine Laboratory at Cambridge University Hospitals NHS Foundation Trust. Author of over 230 publications and an expert in cytokine analysis. Dr Doffinger is an elected member of the Henry Krunkel Society.

Professor Ben Creagh Brown

Clinical Trial Specialist and Advisor

Professor and Consultant Intensive Care and Respiratory Medicine specialising in perioperative medicine, and sepsis research, with extensive experience in clinical trial design and setup.
Joined team in 2025.

Yannick Bossard

Pharma Supply Chain Expert and Advisor

Mr Bossard (Boston Scientific) brings 15+ years’ experience in pharmaceutical supply chain management, with a proven track record in operational excellence, regulatory compliance, and cost optimisation for global pharma companies.
Joined team in 2025.

Collaborators

Global CRO providing expert drug development, regulatory strategy, and clinical trial management, specialising in complex therapeutic areas for small to mid-sized biotechs.

Premier transaction advisory firm with 30+ years’ experience structuring and negotiating licensing deals, maximizing value for pharma and biotech clients worldwide.

Our Mission

BIOSIRIUS Ltd operates at the intersection of pharmaceutical innovation and strategic IP monetization. Our company specializes in both intellectual property acquisition and research development on biotechnology, giving us a unique dual perspective on the entire drug development lifecycle. This combination of legal and R&D capabilities positions us to evaluate, develop, and license pharmaceutical IP.

Our approach centres on identifying high-value intellectual property assets and crafting strategic licensing agreements that benefit all stakeholders - from pharmaceutical partners seeking innovative therapies to patients awaiting better treatment options. We focus on creating sustainable partnerships that drive innovation while ensuring equitable access to breakthrough medicines.